{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:14:47Z","timestamp":1761851687060,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/pat.0b013e3283634dec","type":"journal-article","created":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T18:19:37Z","timestamp":1373653177000},"page":"508-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiple cytokine- and multiple cytokine receptor-expressing triple-hit B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt\u2019s lymphoma"],"prefix":"10.1016","volume":"45","author":[{"given":"Shoko","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiji","family":"Yokote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motomu","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Hanafusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2008","series-title":"World Health Organization Classification of Tumors. Pathology and Genetics, Tumors of Haematopoietic and Lymphoid Tissues","key":"10.1097\/PAT.0b013e3283634dec_bib0005"},{"key":"10.1097\/PAT.0b013e3283634dec_bib0010","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/cncr.21776","article-title":"Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia","volume":"106","author":"Thomas","year":"2006","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e3283634dec_bib0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00005-010-0066-1","article-title":"ma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index","volume":"58","author":"Lech-Maranda","year":"2010","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1097\/PAT.0b013e3283634dec_bib0020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0145-2126(96)00029-X","article-title":"Promotion of IL8, IL10, TNF alpha and TNF beta production by EBV infection","volume":"20","author":"Klein","year":"1996","journal-title":"Leuk Res"},{"key":"10.1097\/PAT.0b013e3283634dec_bib0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCRESAHA.108.182014","article-title":"Interleukin-6 overexpression induces pulmonary hypertension","volume":"104","author":"Steiner","year":"2009","journal-title":"Circ Res"},{"key":"10.1097\/PAT.0b013e3283634dec_bib0030","first-page":"974s","article-title":"Tumor necrosis factor-alpha- promoted expression ofBcl-2 and inhibition of mitochondrial cytochrome c release mediate resistance of mature dendritic cells to melanoma-induced apoptosis","volume":"7","author":"Esche","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1097\/PAT.0b013e3283634dec_bib0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1074\/jbc.M110.153221","article-title":"IL-6-induced enhancement of c-Myc translation in multiple myeloma cells: critical role of cytoplasmic localization of the rna-binding protein hnRNP A1","volume":"286","author":"Shi","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1097\/PAT.0b013e3283634dec_bib0040","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1038\/sj.onc.1205731","article-title":"Tumour necrosis factor-alpha in Barrett\u2019s oesophagus: a potential novel mechanism of action","volume":"21","author":"Tselepis","year":"2002","journal-title":"Oncogene"},{"key":"10.1097\/PAT.0b013e3283634dec_bib0045","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1182\/blood-2008-12-193037","article-title":"The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL","volume":"113","author":"Ci","year":"2009","journal-title":"Blood"},{"key":"10.1097\/PAT.0b013e3283634dec_bib0050","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ccr.2005.03.037","article-title":"Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice","volume":"7","author":"Cattoretti","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1097\/PAT.0b013e3283634dec_bib0055","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1182\/blood-2010-02-270082","article-title":"A proto-oncogene BCL6 is up- regulated in the bone marrow microenvironment in multiple myeloma cells","volume":"115","author":"Hideshima","year":"2010","journal-title":"Blood"},{"key":"10.1097\/PAT.0b013e3283634dec_bib0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1074\/jbc.M609138200","article-title":"BCL2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis","volume":"282","author":"Patel","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1097\/PAT.0b013e3283634dec_bib0065","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M511914200","article-title":"Bcl2 suppresses DNA repair by enhancing c-Myc transcriptional activity","volume":"281","author":"Jin","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1097\/PAT.0b013e3283634dec_bib0070","doi-asserted-by":"crossref","first-page":"5a","DOI":"10.1182\/blood.V106.11.2.2","article-title":"Pathologic co-expression and physical interaction of C-MYC and BCL6 in B-cell lymphomas","volume":"106","author":"Saito","year":"2005","journal-title":"Blood"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516315240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516315240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:17:39Z","timestamp":1758471459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516315240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0031302516315240"],"URL":"https:\/\/doi.org\/10.1097\/pat.0b013e3283634dec","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple cytokine- and multiple cytokine receptor-expressing triple-hit B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt\u2019s lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/PAT.0b013e3283634dec","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}